Abstract
This report presents a case of multiple gastrointestinal stromal tumors (GIST) with neurofibromatosis type 1 (NF1). A 68-year-old woman was admitted to the hospital because of a tumor close to the head of the pancreas. Imaging studies revealed submucosal tumors of the duodenum. The retroperitoneal tumor was diagnosed before surgery. Besides the main tumor in the duodenum, multiple small submucosal tumors were found in the duodenum and upper part of the jejunum during the operation. All of these tumors were resected. The histological diagnosis of all these tumors was GISTs. These tumors were immunohistochemically positive for KIT, but they demonstrated no mutation in c-kit exons 9, 11, 13, and 17, and platelet-derived growth factor receptor α exons 12 and 18. No recurrence occurred for a year after surgery.
Similar content being viewed by others
References
Rasmussen SA, Friedman JM. NF1 gene and neurofibromatosis. Am J Epidemiol 2000;151:33–40.
Anderson J, Sihto H, Meis-Kindblom JM, Joensuu H, Nupponen N, Kindblom LG. NF1-associated gastrointestinal stromal tumors have unique clinical, phenotypic, and genotypic characteristics. Am J Surg Pathol 2005;29:1170–1176.
Yantiss RK, Rosenberg AE, Sarran L, Besmer P, Antonescu CR. Multiple gastrointestinal stromal tumors in type I neurofibromatosis: a pathologic and molecular study. Mod Pathol 2005;18:475–484.
Tsukuda K, Hirai R, Miyake T, Takagi S, Ikeda E, Kunitomo T, et al. The outcome of gastrointestinal stromal tumors (GISTs) after a surgical resection in our institute. Surg Today 2007;37:953–957.
Hochberg FH, Dasilva AB, Galdavini J, Richardson EP. Gastrointestinal involvement in von Recklinghausen’s neurofibromatosis. Neurology 1974;24:1144–1151.
Takazawa Y, Sakurai S, Sakuma Y, Ikeda T, Yamaguchi J, Hashizume Y, et al. Gastrointestinal stromal tumors of neurofibromatosis type I (von Recklinghausen’s disease). Am J Surg Pathol 2005;29:755–763.
Nilson B, Anderson A, Ahlman H. Adjuvant and down-staging treatment with imatinib in gastrointestinal stromal tumors. J Surg Oncol 2008;98:145–146.
Chen LL, Trent JC, Wu EF, Fuller GN, Ramdas L, Zhang W, et al. A missense mutation in KIT kinase domain 1 correlates with imatinib resistance in gastrointestinal stromal tumors. Cancer Res 2004;64:5913–5919.
Utsunomiya T, Okamoto M, Yano S, Kameyama T, Matsuyama A, Kuma S, et al. Secondary c-kit mutation in a recurrent gastrointestinal stromal tumor under long-term treatment with imatinib mesylate: report of a case. Surg Today 2008;38:65–67.
Miettinen M, Fetsch JF, Sobin LH, Lasota J. Gastrointestinal stromal tumors in patients with neurofibromatosis 1: a clinico-pathologic and molecular genetic study of 45 cases. Am J Surg Pathol 2006;30:90–96.
Hirota S, Isozaki K, Moriyama Y, Hashimoto K, Nishida T, Ishiguro S, et al. Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors. Science 1998;279:577–580.
Cawthon RM, Weiss R, Xu GF, Viskochil D, Culver M, Stevens J, et al. A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell 1990;62:193–201.
Martin GA, Viskochil D, Bollag G, McCabe PC, Crosier WJ, Haubruck H, et al. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 1990;63:843–849.
Li Y, O’Connell P, Breidenbach HH, Cawthon R, Stevens J, Xu G, et al. Genomic organization of the neurofibromatosis 1 gene (NF1). Genomics 1995;25:9–18.
Xu GF, O’Connell P, Viskochil D, Cawthon R, Robertson M, Culver M, et al. The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell 1990;62:599–608.
Maertens O, Prenen H, Debiec-Rychter M, Wozniak A, Sciot R, Pauwels P, et al. Molecular pathogenesis of multiple gastrointestinal stromal tumors in NF1 patients. Hum Mol Genet 2006;15:1015–1023.
Badache A, Muja N, De Vries GH. Expression of Kit in neurofibromin-deficient human Schwann cell: role in Schwann cell hyperplasia associated with type 1 Neurofibromatosis. Oncogene 1998;17:795–800.
Patrakitkomjorn S, Kobayashi D, Morikawa T, Wilson MM, Tsubota N, Irie A, et al. Neurofibromatosis type 1 (NF1) tumor suppressor, neurofibromin, regulates the neuronal differentiation of PC12 cells via its associating protein, CRMP-2. J Biol Chem 2008;283:9399–9413.
Kinoshita K, Hirota S, Isozaki K, Ohashi A, Nishida T, Kitamura Y, et al. Absence of c-kit gene mutations in gastrointestinal stromal tumours from neurofibromatosis type 1 patients. J Pathol 2004;202:80–85.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hirashima, K., Takamori, H., Hirota, M. et al. Multiple gastrointestinal stromal tumors in neurofibromatosis type 1: Report of a case. Surg Today 39, 979–983 (2009). https://doi.org/10.1007/s00595-009-3963-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00595-009-3963-3